Close Menu
Dailyza | Tech, Investments, Business & World News
  • Startups
  • Venture Capital
  • World
  • Economy
  • Politics
  • Science
  • Technology
  • Travel
  • Culture
Facebook X (Twitter) Instagram
Trending
  • Orcan Energy targets AI data centers with waste-heat power
  • Donald Trump Ousts Pam Bondi Over Epstein Files and Rival Probes
  • Monzo exits US market to double down on Europe and IPO bid
  • Jake Paul’s Anti Fund bets on attention as a VC edge
  • Brilliance secures €6M to advance integrated RGB laser chips
  • Wearable Robotics secures €5M to advance rehab exoskeletons
  • Paysend secures $25M to speed up global money transfers
  • SMEY unveils Lipid Atlas, an AI platform for lipidomics
Dailyza | Tech, Investments, Business & World NewsDailyza | Tech, Investments, Business & World News
Saturday, April 4
  • Startups
  • Venture Capital
  • World
  • Economy
  • Politics
  • Science
  • Technology
  • Travel
  • Culture
Dailyza | Tech, Investments, Business & World News
Home»Venture Capital
British Business Bank and Empirical Ventures partnership supporting UK deeptech startups beyond the lab

British Business Bank backs Empirical Ventures with extra £10M

31 March 2026 Venture Capital No Comments2 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

British Business Bank boosts Empirical Ventures with new £10M

The UK’s state-backed development bank, the British Business Bank, has committed a further £10 million to specialist investor Empirical Ventures, strengthening the country’s early-stage deeptech ecosystem and helping research-intensive startups move from lab prototypes to market-ready products.

The new capital, deployed through the Bank’s Enterprise Capital Funds programme, will expand Empirical Ventures’ firepower for backing pre-seed and seed-stage companies in areas such as advanced materials, quantum technologies, next-generation computing, and cutting-edge hardware.

Backing deeptech beyond the lab

Empirical Ventures focuses on founders emerging from universities and research institutes, where commercialisation gaps often prevent promising science from reaching industry. Deeptech startups typically face long development cycles, heavy R&D investment, and complex regulatory paths, making access to patient capital critical.

The additional £10 million commitment is designed to help bridge the notorious “valley of death” between proof-of-concept and scalable commercial deployment. By increasing the fund’s capacity, the partnership aims to support more spinouts and early-stage teams with both capital and specialist expertise.

Strategic role for the British Business Bank

The British Business Bank uses the Enterprise Capital Funds scheme to crowd in private investors and build a more resilient UK venture capital market. Its support for sector-focused funds like Empirical Ventures is part of a broader strategy to keep high-potential science and technology companies rooted in the UK, rather than seeking growth capital overseas.

Industry observers see the move as a signal of continued confidence in the UK’s deeptech pipeline despite a tougher fundraising environment. By reinforcing specialist investors that understand complex IP, hardware-heavy business models, and long development timelines, the Bank aims to turn world-class research into globally competitive businesses and high-value jobs.

The expanded fund is expected to back a larger portfolio of companies over the coming years, providing early capital, hands-on support and access to networks that can help UK deeptech startups progress from lab bench to large-scale deployment.

Previous ArticleDailyza ranks top custom software development firms for 2026
Next Article Insight Partners backs ScaleOps with $130M to tame cloud chaos
Kenyon Shah
  • Website

Keep Reading

Jake Paul’s Anti Fund bets on attention as a VC edge

Barclays backs £130M ‘Women Backing Women’ VC fund push

European startups secure fresh capital in early April surge

Generare secures €20M from Alven, Daphni to turbocharge drug R&D

Rupa Popat on Arāya Ventures and the Future of Impact VC

Generare raises €20M to decode microbial genomes for drugs

Add A Comment

Leave A Reply Cancel Reply

Jake Paul’s Anti Fund bets on attention as a VC edge

Venture Capital 3 April 2026

Anti Fund, co-founded by Jake Paul, is pitching a new venture model built on attention, disciplined execution and long-term trust, not celebrity hype.

SMEY unveils Lipid Atlas, an AI platform for lipidomics

Barclays backs £130M ‘Women Backing Women’ VC fund push

European startups secure fresh capital in early April surge

Generare secures €20M from Alven, Daphni to turbocharge drug R&D

Rupa Popat on Arāya Ventures and the Future of Impact VC

Generare raises €20M to decode microbial genomes for drugs

British Business Bank Unites Major Investors in New Fund

Runway Fund backs early AI and media startups worldwide

Connectome secures $2M to detect silent brain decline early

Kleiner Perkins Backs Saronic in $1.75B Bet on US Autonomy

MOVEMENTS secures €300k pre-seed to power values-led campaigns

EU-Startups Summit 2026 unveils leading space innovators

Metafuels wins €1.92M Dutch grant for Rotterdam e-SAF plant

Alice & Bob wins €3.4M ARPA-E grant for quantum magnets

Dailyza | Tech, Investments, Business & World News
  • Startups
  • Contact
  • About Us
© 2026 Dailyza

Type above and press Enter to search. Press Esc to cancel.